Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200475180> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W4200475180 endingPage "595" @default.
- W4200475180 startingPage "587" @default.
- W4200475180 abstract "To describe dispensation patterns of glucose-lowering drugs in newly diagnosed type 2 diabetes in Germany.Based on claims data from four statutory health insurances (German Pharmacoepidemiological Research Database,>25 million insurants), all individuals with newly diagnosed type 2 diabetes were identified. Eligible patients had a first diagnosis for type 2 diabetes between January 2012 and December 2016. We analyzed the dispensation patterns of first-line glucose-lowering therapies initiated in the year after diabetes diagnosis and patterns of second-line therapies dispensed one year after first-line treatment.A total of 356,647 individuals with newly diagnosed type 2 diabetes were included (average age [SD]: 63.5 [13.4] years; 49.3% males). Of the 31.6% of individuals who were pharmacologically treated in the year after diagnosis, metformin monotherapy was most frequently dispensed (73.1%), followed by dual therapy of metformin and dipeptidyl peptidase-4 inhibitors (DPP-4is) (6.4%), and monotherapy with DPP-4is (2.9%). From 2012 through 2016, sulfonylurea dispensations were reduced by more than 50%. Dispensations for combination therapies with DPP-4is increased up to 10.6%. Glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors contributed to 2% of all treatments. After a median of 5 months, 20.0% of individuals on pharmacological therapy initiated second-line glucose-lowering treatment.Data from German statutory health insurances (2012 to 2016) showed that most individuals with newly diagnosed type 2 diabetes were dispensed metformin monotherapy in line with diabetes care guidelines. A substantial decrease in the use of sulfonylureas was observed after the introduction of DPP-4i and GLP-1 receptor agonists." @default.
- W4200475180 created "2021-12-31" @default.
- W4200475180 creator A5021542554 @default.
- W4200475180 creator A5033855594 @default.
- W4200475180 creator A5037611493 @default.
- W4200475180 creator A5067796093 @default.
- W4200475180 creator A5068207171 @default.
- W4200475180 date "2021-12-23" @default.
- W4200475180 modified "2023-09-26" @default.
- W4200475180 title "Dispensation Patterns of Glucose-Lowering Drugs in Newly Diagnosed Type 2 Diabetes: Routine Data Analysis of Insurance Claims in Germany" @default.
- W4200475180 cites W1627590458 @default.
- W4200475180 cites W1805721213 @default.
- W4200475180 cites W1987381358 @default.
- W4200475180 cites W1998627915 @default.
- W4200475180 cites W1999492053 @default.
- W4200475180 cites W2053237747 @default.
- W4200475180 cites W2063911109 @default.
- W4200475180 cites W2099468119 @default.
- W4200475180 cites W2124833686 @default.
- W4200475180 cites W2171294019 @default.
- W4200475180 cites W2172193326 @default.
- W4200475180 cites W2264169711 @default.
- W4200475180 cites W2328114764 @default.
- W4200475180 cites W2340612864 @default.
- W4200475180 cites W2497946522 @default.
- W4200475180 cites W2507901651 @default.
- W4200475180 cites W2519510391 @default.
- W4200475180 cites W2538344831 @default.
- W4200475180 cites W2582002767 @default.
- W4200475180 cites W2614137535 @default.
- W4200475180 cites W2746874591 @default.
- W4200475180 cites W2747454477 @default.
- W4200475180 cites W2768576350 @default.
- W4200475180 cites W2781629701 @default.
- W4200475180 cites W2883124576 @default.
- W4200475180 cites W2913914029 @default.
- W4200475180 cites W4246340431 @default.
- W4200475180 doi "https://doi.org/10.1055/a-1702-5151" @default.
- W4200475180 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34942670" @default.
- W4200475180 hasPublicationYear "2021" @default.
- W4200475180 type Work @default.
- W4200475180 citedByCount "0" @default.
- W4200475180 crossrefType "journal-article" @default.
- W4200475180 hasAuthorship W4200475180A5021542554 @default.
- W4200475180 hasAuthorship W4200475180A5033855594 @default.
- W4200475180 hasAuthorship W4200475180A5037611493 @default.
- W4200475180 hasAuthorship W4200475180A5067796093 @default.
- W4200475180 hasAuthorship W4200475180A5068207171 @default.
- W4200475180 hasConcept C126322002 @default.
- W4200475180 hasConcept C134018914 @default.
- W4200475180 hasConcept C187212893 @default.
- W4200475180 hasConcept C2777180221 @default.
- W4200475180 hasConcept C2780323712 @default.
- W4200475180 hasConcept C555293320 @default.
- W4200475180 hasConcept C71924100 @default.
- W4200475180 hasConceptScore W4200475180C126322002 @default.
- W4200475180 hasConceptScore W4200475180C134018914 @default.
- W4200475180 hasConceptScore W4200475180C187212893 @default.
- W4200475180 hasConceptScore W4200475180C2777180221 @default.
- W4200475180 hasConceptScore W4200475180C2780323712 @default.
- W4200475180 hasConceptScore W4200475180C555293320 @default.
- W4200475180 hasConceptScore W4200475180C71924100 @default.
- W4200475180 hasIssue "09" @default.
- W4200475180 hasLocation W42004751801 @default.
- W4200475180 hasLocation W42004751802 @default.
- W4200475180 hasOpenAccess W4200475180 @default.
- W4200475180 hasPrimaryLocation W42004751801 @default.
- W4200475180 hasRelatedWork W1891939305 @default.
- W4200475180 hasRelatedWork W2032746366 @default.
- W4200475180 hasRelatedWork W2071602074 @default.
- W4200475180 hasRelatedWork W2123889964 @default.
- W4200475180 hasRelatedWork W2133632105 @default.
- W4200475180 hasRelatedWork W2166498497 @default.
- W4200475180 hasRelatedWork W2896883278 @default.
- W4200475180 hasRelatedWork W3116386123 @default.
- W4200475180 hasRelatedWork W3117885438 @default.
- W4200475180 hasRelatedWork W3130171081 @default.
- W4200475180 hasVolume "130" @default.
- W4200475180 isParatext "false" @default.
- W4200475180 isRetracted "false" @default.
- W4200475180 workType "article" @default.